CoChat

TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis

Open access
Zhang, Yang, Cai, Pengcheng, Liang, Tao, Wang, Lin, Hu, Lihua · 2017 · Oncotarget
Cited by 98

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

// Yang Zhang 1 , Pengcheng Cai 1 , Tao Liang 1 , Lin Wang 1, 2 and Lihua Hu 1 1 Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China 2 Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China Correspondence to: Lihua Hu, email: lihuahu@hust.edu.cn Lin Wang, email: katelinwang@126.com Keywords: TIM-3, meta-analysis, solid tumor, prognostic marker, overall survival Received: August 29, 2016 Accepted: February 21, 2017 Published: March 07, 2017 ABSTRACT Accumulated studies have demonstrated the important role of T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) in various solid tumors and indicated its correlation with patients’ survival. To further verify the prognostic significance of TIM-3 in cancer patients and its correlation with tumor, we performed this meta-analysis including seven studies searched from PubMed, Web of Science, and Embase till July 2016. A total of 869 patients were used to analyze the association between TIM-3 expression and patients’ overall survival (OS). The pooled results showed that higher expression of TIM-3 was significantly correlated to shorter OS (7 studies, HR=1.89; 95% CI: 1.38-2.57; P< 0.001). In addition, higher TIM-3 expression was associated with advanced tumor stage (3 studies, III/IV vs. I/II, RR=2.02; 95% CI: 1.45–2.81; P< 0.001). In conclusion, our study highlights the role of TIM-3 as a potential prognostic marker and a promising therapeutic target in solid tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.15954

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 98

Metadata

Authors
Zhang, Y., Cai, P., Liang, T., Wang, L., & Hu, L.
Venue
Oncotarget
Published
2017-03-07
Volume
8
Issue
19
Pages
31705-31713
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2594323422
Cited by
98
References
6
FWCI
1.00
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.18632/oncotarget.15954
The paper
Zhang, Y., Cai, P., Liang, T., Wang, L., & Hu, L. (2017). TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis. Oncotarget. https://doi.org/10.18632/oncotarget.15954

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.